AGCO Earnings 2020-09-30

Balance Sheet	Income Statement	Cash Flow
Assets, Equity	Rev, G Profit, Net Income	Ops, Inv, Fin

agco-20200930

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q



☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
			For the transition period from _________ to _________

Commission File Number: 001-12930

AGCO CORPORATION

(Exact name of Registrant as specified in its charter)


Delaware		58-1960019
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
4205 River Green Parkway
Duluth,	Georgia	30096
(Address of principal executive offices)		(Zip Code)

(770) 813-9200

(Registrants telephone number, including area code)


Securities registered pursuant to Section 12(b) of the Act
Title of Class	Trading Symbol	Name of exchange on which registered
Common stock	AGCO	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

☒ Yes o No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

☒ Yes o No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☒

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of November 2, 2020, there were 74,899,512 shares of the registrant’s common stock, par value of $0.01 per share, outstanding.

AGCO CORPORATION AND SUBSIDIARIES

INDEX


			Page Numbers

PART I. FINANCIAL INFORMATION:

Item 1.	Financial Statements (unaudited)

		Condensed Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019	3

		Condensed Consolidated Statements of Operations for the Three Months Ended September 30, 2020 and 2019	4

		Condensed Consolidated Statements of Operations for the Nine Months Ended September 30, 2020 and 2019	5

		Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended September 30, 2020 and 2019	6

		Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2020 and 2019	7

	Notes to Condensed Consolidated Financial Statements		8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		37

Item 3.	Quantitative and Qualitative Disclosures about Market Risk		47

Item 4.	Controls and Procedures		47

PART II. OTHER INFORMATION:

Item 1.	Legal Proceedings		48

Item 1A.	Risk Factors		48

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		49

Item 6.	Exhibits		50

SIGNATURES			51

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

AGCO CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited and in millions, except share amounts)


	September 30, 2020		December 31, 2019
ASSETS
Current Assets:
Cash and cash equivalents	$	511.0	$	432.8
Accounts and notes receivable, net	990.1		800.5
Inventories, net	2,057.1		2,078.7
Other current assets	386.5		417.1
Total current assets	3,944.7		3,729.1
Property, plant and equipment, net	1,413.7		1,416.3
Right-of-use lease assets	178.9		187.3
Investment in affiliates	411.3		380.2
Deferred tax assets	69.7		93.8
Other assets	186.5		153.0
Intangible assets, net	462.2		501.7
Goodwill	1,273.3		1,298.3
Total assets	$	7,940.3	$	7,759.7
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Current portion of long-term debt	$	86.2	$	2.9
Short-term borrowings	47.7		150.5

Accounts payable	819.9		914.8
Accrued expenses	1,691.9		1,654.2
Other current liabilities	211.8		162.1
Total current liabilities	2,857.5		2,884.5
Long-term debt, less current portion and debt issuance costs	1,429.3		1,191.8
Operating lease liabilities	139.1		148.6
Pension and postretirement health care benefits	224.6		232.1
Deferred tax liabilities	106.6		107.0
Other noncurrent liabilities	333.3		288.7
Total liabilities	5,090.4		4,852.7
Commitments and contingencies (Note 18)

Stockholders’ Equity:
AGCO Corporation stockholders’ equity:
Preferred stock; $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding in 2020 and 2019	—		—
Common stock; $0.01 par value, 150,000,000 shares authorized, 74,899,318 and 75,471,562 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively	0.8		0.8
Additional paid-in capital	24.2		4.7
Retained earnings	4,635.7		4,443.5
Accumulated other comprehensive loss	(1,851.0)		(1,595.2)
Total AGCO Corporation stockholders’ equity	2,809.7		2,853.8
Noncontrolling interests	40.2		53.2
Total stockholders’ equity	2,849.9		2,907.0
Total liabilities and stockholders’ equity	$	7,940.3	$	7,759.7

See accompanying notes to condensed consolidated financial statements.

Table of Contents

AGCO CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited and in millions, except per share data)



	Three Months Ended September 30,
	2020		2019
Net sales	$	2,497.5	$	2,109.4
Cost of goods sold	1,918.8		1,659.2
Gross profit	578.7		450.2
Selling, general and administrative expenses	251.3		245.0
Operating expenses:
Engineering expenses	82.0		82.3
Amortization of intangibles	14.8		14.9

Bad debt expense	5.8		0.8
Restructuring expenses	0.8		1.3
Income from operations	224.0		105.9
Interest expense, net	3.6		6.4
Other expense, net	15.3		20.8
Income before income taxes and equity in net earnings of affiliates	205.1		78.7
Income tax provision	57.2		83.2
Income (loss) before equity in net earnings of affiliates	147.9		(4.5)
Equity in net earnings of affiliates	10.2		10.8
Net income	158.1		6.3
Net (income) loss attributable to noncontrolling interests	(0.8)		1.3
Net income attributable to AGCO Corporation and subsidiaries	$	157.3	$	7.6
Net income per common share attributable to AGCO Corporation and subsidiaries:
Basic	$	2.10	$	0.10
Diluted	$	2.09	$	0.10
Cash dividends declared and paid per common share	$	0.16	$	0.16
Weighted average number of common and common equivalent shares outstanding:
Basic	74.9		76.1
Diluted	75.4		76.7

See accompanying notes to condensed consolidated financial statements.

Table of Contents

AGCO CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited and in millions, except per share data)


	Nine Months Ended September 30,
	2020		2019
Net sales	$	6,432.6	$	6,527.8
Cost of goods sold	4,970.7		5,057.0
Gross profit	1,461.9		1,470.8
Selling, general and administrative expenses	718.4		767.9
Operating expenses:
Engineering expenses	242.7		254.3
Amortization of intangibles	44.7		45.6
Goodwill impairment charge	20.0		—
Bad debt expense	9.0		2.1
Restructuring expenses	5.4		3.0
Income from operations	421.7		397.9
Interest expense, net	13.1		15.9
Other expense, net	37.8		47.0
Income before income taxes and equity in net earnings of affiliates	370.8		335.0
Income tax provision	117.9		155.8
Income before equity in net earnings of affiliates	252.9		179.2
Equity in net earnings of affiliates	31.5		33.2
Net income	284.4		212.4
Net loss attributable to noncontrolling interests	7.3		1.1
Net income attributable to AGCO Corporation and subsidiaries	$	291.7	$	213.5
Net income per common share attributable to AGCO Corporation and subsidiaries:
Basic	$	3.89	$	2.79
Diluted	$	3.86	$	2.77
Cash dividends declared and paid per common share	$	0.48	$	0.47
Weighted average number of common and common equivalent shares outstanding:
Basic	75.0		76.4
Diluted	75.5		77.1

See accompanying notes to condensed consolidated financial statements.

Table of Contents

AGCO CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(unaudited and in millions)


	Three Months Ended September 30,
	2020		2019
Net income	$	158.1	$	6.3
Other comprehensive loss, net of reclassification adjustments:
Foreign currency translation adjustments	(30.3)		(62.7)
Defined benefit pension plans, net of tax	3.4		2.8
Deferred gains and losses on derivatives, net of tax	(1.1)		(1.6)
Other comprehensive loss, net of reclassification adjustments	(28.0)		(61.5)
Comprehensive income (loss)	130.1		(55.2)
Comprehensive loss attributable to noncontrolling interests	1.4		2.0
Comprehensive income (loss) attributable to AGCO Corporation and subsidiaries	$	131.5	$	(53.2)


	Nine Months Ended September 30,
	2020		2019
Net income	$	284.4	$	212.4
Other comprehensive loss, net of reclassification adjustments:
Foreign currency translation adjustments	(275.4)		(46.1)
Defined benefit pension plans, net of tax	10.3		8.8
Deferred gains and losses on derivatives, net of tax	3.9		(0.9)
Other comprehensive loss, net of reclassification adjustments	(261.2)		(38.2)
Comprehensive income	23.2		174.2
Comprehensive loss (income) attributable to noncontrolling interests	12.7		(0.4)
Comprehensive income attributable to AGCO Corporation and subsidiaries	$	35.9	$	173.8

See accompanying notes to condensed consolidated financial statements.

Table of Contents

AGCO CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited and in millions)


	Nine Months Ended September 30,
	2020		2019
Cash flows from operating activities:
Net income	$	284.4	$	212.4
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	154.9		159.2
Amortization of intangibles	44.7		45.6
Stock compensation expense	26.8		32.9
Goodwill impairment charge	20.0		—
Equity in net earnings of affiliates, net of cash received	(30.9)		(26.3)
Deferred income tax provision	2.4		43.1
Other	19.2		1.9
Changes in operating assets and liabilities:
Accounts and notes receivable, net	(264.7)		(85.1)
Inventories, net	(53.4)		(503.4)
Other current and noncurrent assets	(39.5)		(47.0)
Accounts payable	(55.6)		(4.1)
Accrued expenses	22.9		23.7
Other current and noncurrent liabilities	92.9		66.9
Total adjustments	(60.3)		(292.6)
Net cash provided by (used in) operating activities	224.1		(80.2)
Cash flows from investing activities:
Purchases of property, plant and equipment	(183.1)		(188.1)
Proceeds from sale of property, plant and equipment	0.9		0.9
Investments in unconsolidated affiliates	(4.7)		—
Purchase of businesses, net of cash acquired	(2.8)		—


Net cash used in investing activities	(189.7)		(187.2)
Cash flows from financing activities:
Proceeds from indebtedness	1,195.6		1,998.3
Repayments of indebtedness	(1,027.7)		(1,600.5)
Purchases and retirement of common stock	(55.0)		(100.0)
Payment of dividends to stockholders	(36.0)		(35.9)
Payment of minimum tax withholdings on stock compensation	(16.2)		(27.5)
Payment of debt issuance costs	(1.4)		(0.5)
Investment by noncontrolling interests	0.2		1.2

Net cash provided by financing activities	59.5		235.1
Effects of exchange rate changes on cash, cash equivalents and restricted cash	(15.7)		(11.8)
Increase (decrease) in cash, cash equivalents and restricted cash	78.2		(44.1)
Cash, cash equivalents and restricted cash, beginning of period	432.8		326.1
Cash, cash equivalents and restricted cash, end of period	$	511.0	$	282.0

See accompanying notes to condensed consolidated financial statements.

Table of Contents

AGCO CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1. BASIS OF PRESENTATION

The condensed consolidated financial statements of AGCO Corporation and its subsidiaries (the “Company” or “AGCO”) included herein have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which are of a normal recurring nature, necessary to present fairly the Company’s financial position, results of operations, comprehensive income (loss) and cash flows at the dates and for the periods presented. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Results for interim periods are not necessarily indicative of the results for the year.

The Company cannot predict the ongoing impact of the coronavirus (“COVID-19”) pandemic due to increased volatility in global economic and political environments, uncertain market demand for its products, supply chain disruptions, possible workforce unavailability, exchange rate and commodity price volatility and availability of financing, and their impact to the Company’s net sales, production volumes, costs and overall financial condition and available funding. The Company may be required to record significant impairment charges in the future with respect to noncurrent assets such as goodwill and other intangible assets and equity method investments, whose fair values may be negatively affected by the COVID-19 pandemic. The Company also may be required to write-down obsolete inventory due to decreased customer demand and sales orders. The Company is closely monitoring the collection of accounts receivable, as well as the operating results of its finance joint ventures around the world. If economic conditions around the world continue to deteriorate, the Company and its finance joint ventures may not collect accounts receivable at expected levels, and the operating results of its finance joint ventures may be negatively impacted, thus negatively impacting the Company’s results of operations and financial condition. The Company also is closely assessing its compliance with debt covenants, the recognition of any future insurance recoveries, cash flow hedging forecasts as compared to actual transactions, the fair value of pension assets, accounting for incentive and stock compensation accruals, revenue recognition and discount reserve setting as well as the realization of deferred tax assets in light of the COVID-19 pandemic.

Recently Adopted Accounting Pronouncements

In March 2020, the FASB issued ASU 2020-04, “Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”), which provides temporary accounting relief for contract modifications to ease the financial reporting burdens related to the expected market transition from LIBOR and other interbank offered rates to a new alternative reference rate. ASU 2020-04 can be applied as of the beginning of the interim period that includes March 12, 2020 or any date thereafter. ASU 2020-04 generally will no longer be available to apply after December 31, 2022. Interest on U.S. dollar borrowings under the Company's credit facility and its April 2020 amendment is calculated based upon LIBOR. In the event that LIBOR is no longer published, interest will be calculated upon a base rate. The credit facility and its April 2020 amendment provide for an expedited amendment process once a replacement for LIBOR is established (see Note 5). The Company adopted this standard as of March 31, 2020. The adoption did not have a material impact to the Company’s results of operations, financial condition and cash flows.

In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”), which requires measurement and recognition of expected versus incurred credit losses for financial assets held. ASU 2016-13 is effective for annual periods beginning after December 15, 2019, and interim periods within those annual periods as the adoption of the standard relates to the Company. In April 2019, the FASB issued ASU 2019-04, “Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments” (“ASU 2019-04”), which provides, among other things, targeted improvements to certain aspects of accounting for credit losses addressed by ASU 2016-13. In November 2019, the FASB issued ASU 2019-11, “Codification Improvements to Topic 326), Financial Instruments - Credit Losses,” which clarifies the treatment of expected recoveries for amounts previously written-off on purchased receivables, provides transition relief for troubled debt restructurings and allows for certain disclosure simplifications of accrued interest. The effective dates for both ASU 2019-04 and ASU 2019-11 are the same as the effective dates for ASU 2016-13. The Company adopted this standard, and its subsequent modifications, as of

Table of Contents

Notes to Condensed Consolidated Financial Statements - Continued

(unaudited)

January 1, 2020. The adoption did not have a material impact to the Company’s results of operations, financial condition and cash flows.

New Accounting Pronouncements to be Adopted

In December 2019, the FASB issued ASU 2019-12, “Simplifying the Accounting for Income Taxes,” which simplifies various aspects related to accounting for income taxes by removing certain exceptions for investments, intraperiod allocations and interim calculations, and adding guidance to reduce complexity in accounting for income taxes. ASU 2019-12 is effective for annual periods beginning after December 15, 2020, and interim periods within those annual periods using a prospective approach. Early adoption is permitted. Depending on the amendment, adoption may be applied on the retrospective, modified retrospective or prospective basis. The standard will not have a material impact on the Company's results of operations, financial condition and cash flows.

As discussed above, in June 2016, the FASB issued ASU 2016-13, which requires measurement and recognition of expected versus incurred credit losses for financial assets held. In November 2019, the FASB issued ASU 2019-10, “Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates,” which delays the effective date of ASU 2016-13 for smaller reporting companies and other non-SEC reporting entities. This applies to the Company’s equity method finance joint ventures who are now required to adopt ASU 2016-13 for annual periods beginning after December 15, 2022 and interim periods within those annual periods. The standard, and its subsequent modification, will likely impact the results of operations and financial condition of the Company’s finance joint ventures. Therefore, adoption of the standard by the Company’s finance joint ventures will likely impact the Company’s “Investment in affiliates” and “Equity in net earnings of affiliates.” The Company’s finance joint ventures currently are evaluating the impact of ASU 2016-13 to their results of operations and financial condition.

Table of Contents

Notes to Condensed Consolidated Financial Statements - Continued

(unaudited)

2. RESTRUCTURING EXPENSES

From 2014 through 2020, the Company announced and initiated several actions to rationalize employee headcount at various manufacturing facilities and various administrative offices located in Europe, South America, Africa, China and the United States in order to reduce costs in response to softening global market demand and lower production volumes. The aggregate headcount reduction was approximately 4,160 employees between 2014 and 2019. In addition, during 2019, the Company initiated various restructuring activities in an effort to rationalize its grain storage and protein production system operations. During the nine months ended September 30, 2020, the Company recorded severance and related costs associated with further rationalizations in connection with the termination of approximately 320 employees. Restructuring expenses activity during the three and nine months ended September 30, 2020 is summarized as follows (in millions):


	Write-down of Property, Plant and Equipment		Employee Severance		Facility Closure Costs		Total
Balance as of December 31, 2019	$	—	$	4.8	$	—	$	4.8
First quarter 2020 provision	—		0.7		0.2		0.9

First quarter 2020 provision reversal	—		(0.1)		—		(0.1)
First quarter 2020 cash activity	—		(1.7)		(0.2)		(1.9)
Foreign currency translation	—		(0.1)		—		(0.1)
Balance as of March 31, 2020	$	—	$	3.6	$	—	$	3.6
Second quarter 2020 provision	1.6		2.2		—		3.8
Less: Non-cash expense	(1.6)		—		—		(1.6)
Cash expense	—		2.2		—		2.2
Second quarter 2020 cash activity	—		(0.8)		—		(0.8)
Foreign currency translation	—		(0.1)		—		(0.1)
Balance as of June 30, 2020	$	—	$	4.9	$	—	$	4.9
Third quarter 2020 provision	—		0.9		—		0.9
Third quarter 2020 cash activity	—		(1.1)		—		(1.1)
Third quarter 2020 provision reversal	—		(0.1)		—		(0.1)

Balance as of September 30, 2020	$	—	$	4.6	$	—	$	4.6

3. STOCK COMPENSATION PLANS

The Company recorded stock compensation expense as follows for the three and nine months ended September 30, 2020 and 2019 (in millions):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Cost of goods sold	$	0.5	$	0.3	$	0.9	$	1.3
Selling, general and administrative expenses	13.7		7.8		26.3		32.0
Total stock compensation expense	$	14.2	$	8.1	$	27.2	$	33.3

Stock Incentive Plan

Under the Company’s Long-Term Incentive Plan (the “Plan”), up to 10,000,000 shares of AGCO common stock may be issued. As of September 30, 2020, of the 10,000,000 shares reserved for issuance under the Plan, approximately 3,252,617 shares were available for grant, assuming the maximum number of shares are earned related to the performance award grants discussed below. The Plan allows the Company, under the direction of the Board of Directors’ Compensation Committee, to make grants of performance shares, stock appreciation rights, restricted stock units and restricted stock awards to employees, officers and non-employee directors of the Company.

Table of Contents

Notes to Condensed Consolidated Financial Statements - Continued

(unaudited)

Long-Term Incentive Plan and Related Performance Awards

The weighted average grant-date fair value of performance awards granted under the Plan during the nine months ended September 30, 2020 and 2019 was $70.84 and $61.01, respectively.

During the nine months ended September 30, 2020, the Company granted 425,440 performance awards related to varying performance periods. The awards granted assume the maximum target levels of performance are achieved. The compensation expense associated with all awards granted under the Plan is amortized ratably over the vesting or performance period based on the Company’s projected assessment of the level of performance that will be achieved.

Performance award transactions during the nine months ended September 30, 2020 were as follows and are presented as if the Company were to achieve its maximum levels of performance under the plan awards:


Shares awarded but not earned at January 1			932,182
Shares awarded			425,440
Shares forfeited			(65,858)
Shares earned			—
Shares awarded but not earned at September 30			1,291,764

As of September 30, 2020, the total compensation cost related to unearned performance awards not yet recognized, assuming the Company’s current projected assessment of the level of performance that will be achieved, was approximately $

Price	76.18	EPS	3
Shares	77	P/E	27
MCap	5,873	P/FCF	-73
Net Debt	1,051	EBIT	370
TEV	6,924	TEV/EBIT	19
TTM 2019-09-30, in MM, except price, ratios

10-Q	2020-09-30	Filed 2020-11-09
10-Q	2020-06-30	Filed 2020-08-07
10-Q	2020-03-31	Filed 2020-05-08
10-K	2019-12-31	Filed 2020-02-28
10-Q	2019-09-30	Filed 2019-11-08
10-Q	2019-06-30	Filed 2019-08-09
10-Q	2019-03-31	Filed 2019-05-09
10-K	2018-12-31	Filed 2019-03-01
10-Q	2018-09-30	Filed 2018-11-08
10-Q	2018-06-30	Filed 2018-08-08
10-Q	2018-03-31	Filed 2018-05-09
10-K	2017-12-31	Filed 2018-02-28
10-Q	2017-09-30	Filed 2017-11-08
10-Q	2017-06-30	Filed 2017-08-08
10-Q	2017-03-31	Filed 2017-05-09
10-K	2016-12-31	Filed 2017-02-28
10-Q	2016-09-30	Filed 2016-11-08
10-Q	2016-06-30	Filed 2016-08-09
10-Q	2016-03-31	Filed 2016-05-06
10-K	2015-12-31	Filed 2016-02-26
10-Q	2015-09-30	Filed 2015-11-09
10-Q	2015-06-30	Filed 2015-08-07
10-Q	2015-03-31	Filed 2015-05-07
10-K	2014-12-31	Filed 2015-02-27
10-Q	2014-09-30	Filed 2014-11-07
10-Q	2014-06-30	Filed 2014-08-08
10-Q	2014-03-31	Filed 2014-05-09
10-K	2013-12-31	Filed 2014-02-28
10-Q	2013-09-30	Filed 2013-11-07
10-Q	2013-06-30	Filed 2013-08-08
10-Q	2013-03-31	Filed 2013-05-08
10-K	2012-12-31	Filed 2013-02-27
10-Q	2012-09-30	Filed 2012-11-07
10-Q	2012-06-30	Filed 2012-08-07
10-Q	2012-03-31	Filed 2012-05-09
10-K	2011-12-31	Filed 2012-02-27
10-Q	2011-09-30	Filed 2011-11-04
10-Q	2011-06-30	Filed 2011-08-05
10-Q	2011-03-31	Filed 2011-05-06
10-K	2010-12-31	Filed 2011-02-25
10-Q	2010-09-30	Filed 2010-11-05
10-Q	2010-06-30	Filed 2010-08-06
10-Q	2010-03-31	Filed 2010-05-07
10-K	2009-12-31	Filed 2010-02-26

8-K	2020-11-03
8-K	2020-08-20
8-K	2020-07-30
8-K	2020-05-05
8-K	2020-04-30
8-K	2020-04-09
8-K	2020-02-06
8-K	2019-10-29
8-K	2019-09-25
8-K	2019-07-30
8-K	2019-05-02
8-K	2019-04-25
8-K	2019-04-24
8-K	2019-02-05
8-K	2019-01-22
8-K	2018-10-30
8-K	2018-10-26
8-K	2018-07-31
8-K	2018-07-25
8-K	2018-05-15
8-K	2018-05-01
8-K	2018-04-26
8-K	2018-02-06

EX-31.1	agcoex311.htm
EX-31.2	agcoex312.htm
EX-32.1	agcoex321.htm

AGCO 10Q Quarterly Report

AGCO Earnings 2020-09-30